
Migraine Science
Duloxetine (Cymbalta): A Potential Off-Label Treatment for Migraine
Posted on May 01 2023,
Click for the full list of the 50 uncommon migraine preventives
What is Duloxetine?
Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI). Therefore, it inhibits the reuptake of serotonin and norepinephrine.

As you can see in this picture, blocking the reuptake (termed reabsorption in the picture) of serotonin and norepinephrine will increase their concentration in the synapses and, therefore, the brain.
Duloxetine is a prescription medication that is FDA-approved for the treatment of major depressive disorder (MDD), generalized anxiety disorder (GAD), diabetic peripheral neuropathic pain (DPNP), fibromyalgia (FM), and chronic musculoskeletal pain. It is also sometimes used off-label for migraine prevention. Many of the aforementioned conditions are also comorbid conditions of migraine and hence why this medication may be more appealing for those patients.
How Does Duloxetine Work?
As we stated earlier, duloxetine works by inhibiting the reuptake of serotonin and norepinephrine thereby increasing their levels in the brain. It is important to note that SNRIs are more effective than SSRIs for migraine prevention although they are both used off-label.
Duloxetine as a Potential Treatment Option for Migraine
There are no randomized controlled trials for duloxetine, but smaller studies are available.
In one study, there was efficacy of duloxetine in patients with coexisting depression and medication overuse due to chronic migraine.
In another study, it was found that migraine prophylactic treatment with high-dose duloxetine may be effective in a nondepressed individual.
Potential Side Effects of Duloxetine
Common side effects of duloxetine include nausea, headache, dry mouth, insomnia, and constipation. If you experience any severe side effects or have concerns about taking this medication, it is important to speak with your healthcare provider.
There is an FDA black box warning against duloxetine as it carries an ncreased risk of suicidal thinking and behavior in children, adolescents, and young adults taking antidepressants for major depressive disorder (MDD) and other psychiatric disorders. Duloxetine is not approved for use in pediatric patients
Other Considerations for Duloxetine
Duloxetine is generally prescribed to those patients that cannot be prescribed venlafaxine.
It is important to talk to your neurologist when planning on stopping this medication.
Do not use duloxetine if you have used an MAO inhibitor in the past 14 days.
Risk of serotonin syndrome if used with triptans, but unlikely. Speak to your healthcare provider.
This is a cursory understanding of uncommon migraine medications. This is only to be used as a resource to go to your neurologist with.
Tue, Sep 08, 26
Botox for Chronic Migraine: What 479 Real-World Patients Show
A 479-patient real-world study of onabotulinumtoxinA for chronic migraine found a mean reduction of 5.9 monthly headache days, with 27.3% reaching the 50% response threshold and 41.6% shedding medication overuse....
Read MoreWed, Sep 02, 26
The New Migraine Prevention Guideline: What the AAN and AHS Recommend
The American Academy of Neurology and the American Headache Society have published a joint practice guideline on migraine prevention in adults: 17 recommendations and 52 statements. It names no single...
Read MoreMigraine Research News: The Best Place to Follow New Migraine Studies Daily
Migraine research moves every week and almost none of it reaches the people who have migraine. Today in Migraine Science is a free page, updated daily, that summarizes the newest...
Read More








